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SUMMARY
Oxidative damage to mitochondrial DNA (mtDNA) has been suggested to be a key factor in the
etiologies of many diseases and in the normal process of aging.  Although the presence of a repair system
to remove this damage has been demonstrated, the mechanisms involved in this repair have not been well-
defined. In an effort to better understand the physiological role of recombinant OGG1 in mtDNA repair, we
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constructed an expression vector, containing the gene for OGG1 downstream of the mitochondrial
localization sequence from MnSOD.  This gene construct was placed under the control of a Tet-regulated
promoter.  Transfected cells that conditionally expressed OGG1 in the absence of the tetracycline analogue
doxycycline and targeted this recombinant protein to mitochondria were generated. Western blots of
mitochondrial extracts, from vector and OGG1 transfected clones with and without doxycycline, revealed
that removal of doxycycline for 4 days caused an approximate eight-fold increase in the amount of OGG1
protein in mitochondria.  Enzyme activity assays and DNA repair studies showed that the doxycycline-
dependant recombinant OGG1 is functional.  Functional studies revealed that cells containing recombinant
OGG1 were more proficient at repairing oxidative damage in their mtDNA, and this increased repair led to
increased cellular survival following oxidative stress.
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INTRODUCTION
The importance of mitochondrial DNA (mtDNA) for cellular integrity and function is underscored
by the fact that a variety of diseases have been associated with mutations in mtDNA, including diabetes  (1,
2) ischemic heart disease (3), Parkinson’s disease (4-6), Alzheimer’s disease (7-9), and the normal process
of aging (10-12).  The damage to mtDNA which leads to these mutations likely results from exposure to
reactive oxygen species (ROS).  These noxious agents are formed continuously in the mitochondria by
electron leakage from the respiratory chains.  Although oxidative phosphorylation in mitochondria is
essential for producing the energy that is required to sustain life, approximately one to two percent of the
total oxygen processed by the electron transport chains is reduced via one electron reduction to form ROS
such as superoxide.  Therefore, mtDNA which is located near the electron transport chains is continuously
bombarded with these noxious agents.  Although there are substantial antioxidant defenses in mitochondria
to protect against the deleterious effects of ROS, damage to mtDNA still occurs.  Therefore, efficient repair
mechanisms are imperative to prevent these lesions from becoming permanent mutations. 
Over the past decade, there have been substantial advances in the understanding of the
mechanisms involved in the repair of oxidative damage in mitochondrial DNA (mtDNA).  Work from our
laboratory and that of others has established that repair of this damage is via a base excision repair (BER)
pathway (13-16).  In support of this notion is the finding that mitochondria contain the basic enzymes
required for BER (17, 18), including the glycosylase/AP lyase OGG1 which is necessary for the initial
steps in the removal of the mutagenic lesion 8-oxoguanine. Because of its lyase activity, this enzyme also
may play a role in cleaning the 3’ end of oxidative lesions to the sugar-phosphate backbone. The human
OGG1 gene encodes two major isoforms: α-hOGG1 and β-hOGG1, resulting from alternative splicing of
the transcript (19-21). Both forms have a putative mitochondrial localization signal and only α-hOGG1
has a nuclear localization signal (21).  Recent studies have shown that β-hOGG1 is targeted to
mitochondria. The importance of the Ogg1 DNA glycosylase in the repair of oxidative damage was shown
in Ogg1-deficient mice.  These animals accumulate abnormally high levels of 8-OxoG in their genomes
(22).  Furthermore, no cleavage of 8-oxoG:C containing substrate was detected in tissue extracts from
Ogg1 knockout mice, indicating that OGG1 is the only mammalian glycosylase that can efficiently remove
8-OxoG from 8-oxoG:C pairs.  These findings correlate well with previous data on the substrate
specificity of the murine and human OGG1 enzyme (23, 24).  Although extracts of Ogg1 null mouse tissues
were not able to excise the damaged base in vitro, significant slow release of the adducted base was
observed from proliferating cells in vivo, suggesting that there is an alternative repair pathway in those
cells (22).  More recently, studies were reported by Bohr et al. (25) that used Ogg1 null mice to show that
OGG1 is more important in mitochondrial than in nuclear DNA repair of oxidative damage (22).  Based on
these studies, it is likely that OGG1 is the only glycosylase for 8-OxoG removal in mouse mitochondria.
Additionally, it was found that mitochondrial OGG1 activity increased with age in the mouse liver (26),
whereas the nuclear OGG1 activity decreased slightly over the same time interval.  This differential change
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with age in the mitochondrial and nuclear 8-OxoG glycosylase activities suggests that the expression of
these two isoforms may be differentially regulated. When considered together, these findings indicate that
BER initiated by OGG1 is an essential enzyme required for protection of mtDNA against oxidative
damage.
Previous studies from our laboratory have shown that mitochondrial DNA repair and cellular
survival can be enhanced by targeting recombinant OGG1 to mitochondria (27). However, to fully evaluate
the potential of using recombinant repair enzymes to alter mtDNA repair, it would be very beneficial to
have their expression under the control of an inducible promoter. The tetracycline (Tet)–regulatable
expression system using control elements of the tetracycline resistance operon encoded in Tn10 of E. coli 
(28) has shown promise for conditional gene expression.  This system relies on the presence or absence of
tetracycline (Tet) or a commonly used analog, doxycyclin (Dox), to control gene expression.  For this
study, we constructed a vector containing the sequence for hOGG1 downstream of the MnSOD
mitochondrial targeting sequence under the control of the Tet-response element and introduced it into
HeLa cells previously transfected with pTet-Off plasmid.  When hOGG1 was conditionally expressed, we
investigated the level and location of the recombinant protein and its effect on mtDNA repair and cell
survival following exposure to ROS.  The results demonstrate that DNA repair proteins can be
conditionally expressed under the control of an inducible promoter and targeted to mitochondria. The Tet-
dependent overexpression of OGG1 causes enhanced repair of oxidative damage to mtDNA and increased
cellular resistance to the lethal effects of ROS.
EXPERIMENTAL PROCEDURES
The OGG1 Construct-An EcoRI –XhoI fragment containing the MTS and the OGG1 coding
region (27) was filled in with Klenow DNA polymerase and ligated into the PvuII restriction site of the
pTRE2hyg expression vector (CLONTECH Laboratories, Inc.), which contained a tetracycline-responsive
element. The construct obtained was sequenced to verify the integrity of the reading frame and the fidelity
of the sequence.
 Cell Culture and Transfection -HeLa cells were obtained from American Type Culture Collection.  The
cells were transfected with pTet-Off plasmid (CLONTECH Laboratories, Inc.) using Fugene 6 reagent
(Roche Molecular Biochemicals) according to the manufacturer’s recommendations.  Stable transfectants
were selected in DMEM (Life Technologies, Inc.) supplemented with 10% fetal bovine serum
(CLONTECH Laboratories, Inc.), 2 mM L-glutamine (Life Technologies, Inc), 800 µg/ml G418
(Geneticin) and 50 µg/ml penicillin/streptomycin (Sigma).  Integration of the pTet-Off plasmid was
confirmed by PCR and expression of the Tet-dependent transactivator (tTa) was tested using the
Luciferase Assay System according to the manufacturers instructions (Promega) in the presence or absence
of 1 µg/ml doxycyclin hydrocloride (Dox, Sigma). Transient transfections with pTRE2hyg/Luc
(CLONTECH Laboratories, Inc.) were performed using Polyfect Transfection Reagent (Qiagen) following
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the manufacturers instructions.  The plasmids pcDNA3.1/His/LacZ (Invitrogen) and pEGFP-N3
(CLONTECH Laboratories, Inc.) containing  β-galactosidase or GFP genes under the control of
constitutive promoters, respectively, were used as reporter plasmids.  The transfection efficiencies were
usually >30 %, as determined by control transfection with pEGFP-N3.  Cells were harvested 48-72 h after
transfection and luciferase activities were assayed.  For normalization of transfection efficiency, a control
LacZ  expression vector (pcDNA3.1/His/LacZ) was used.  Luciferase (Luc) values were normalized to β-
galactosidase activities by performing chlorophenol red β-D-galactosidase (CPRG) -assays (29).  Enzyme
activities were adjusted to the protein content of the cell lysates, which was determined by using the Bio-
Rad protein dye micro-assay according to the manufacturer’s recommendations (Bio-Rad, Hercules, CA).
The clone of HeLa Tet-Off that expressed the lowest basal level of Luc in the presence of Dox and the
highest induced level of Luc activity in the absence of the antibiotic was selected for the second
transfection with pTRE2hyg/MTS-OGG1 plasmid.  A pTRE2hyg vector without the insert was used to
transfect Tet-Off HeLa cells as a control. After this second transfection, the colonies were grown in
DMEM with 800 µg/ml G418 and 250 µg/ml hygromycin B (Life Technologies, Inc.) and the surviving
ones were tested for the integration of MTS-OGG1 insert by Southern hybridization.  The selected Tet-
Off/MTS-OGG1 clones were maintained in DMEM (Life Technologies, Inc.), supplemented with 10%
fetal bovine serum (CLONTECH Laboratories, Inc.), 800 µg/ml G418 (Geneticin), 200 µg/ml hygromycin
B and with (Dox+) or without (Dox-) 1µg/ml doxycyclin.  Doxycyclin was withdrawn from the media of
Dox- maintained clones 4 days before any experiment.
Preparation of Mitochondrial Fractions - One 150 mm dish of each cell type (MTS-OGG1 and
control vector transfected cells) at confluence was harvested and treated with ice-cold digitonin (325 mM
digitonin, 2.5 mM EDTA, 250 mM mannitol, and 17 mM MOPS, pH 7.4) for 80 s.  The lysed cells were
then added to mannitol-sucrose buffer to a final strength of 1X (210 mM mannitol, 70 mM sucrose, 5 mM
EDTA, 5 mMTris, pH 7.5).  The suspension was then centrifuged for 10 min at 800 g at 4oC to pellet
nuclei.  The supernatant was centrifuged two more times for 10 min at 800 g at 4oC to get rid of nuclear
debris.  The mitochondrial fraction was pelleted by centrifugation at 20,000 g at 4oC for 20 min.  Isolated
mitochondria were suspended in a buffer of 20 mM HEPES, pH 7.6; 1 mM  EDTA; 5 mM DTT; 300 mM
KCl; 5% glycerol; and 5 µl of protease inhibitors mixture (Sigma, St. Louis, MO) per ml.  These
suspensions were briefly sonicated on ice, centrifuged once more at 5,000 g to pellet any remaining debris,
and the supernatant protein was used for Western blot assays.  The protein concentration was determined
using the Bio-Rad protein dye micro-assay according to the manufacturer’s recommendation (Bio-Rad,
Hercules, CA).
Western Blot Analysis - SDS-polyacrylamide gel electrophoresis and transfer of separated
proteins to PVDF-membrane were performed as previously described (27) with some minor modifications.
Blocking and antibody immunoblotting were performed in 5% nonfat dry milk and Tris-buffered saline
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with 0.1% Tween 20 (TBS-T). TBS-T and  TBS were used for washing.  The polyclonal anti-hOGG1
antibodies were from Novus Biologicals (Littleton, CO); anti-cytochrome c monoclonal antibody was
purchased from PharMingen (San Diego, CA). Complexes formed by these antibodies were detected with
horse radish peroxidase conjugated anti-mouse IgG or anti-rabbit IgG antibodies (Promega, Madison, WI)
using chemiluminescent reagents (SuperSignal, Pierce, Rockford, IL).
OGG Activity Assays - A 24 -mer oligonucleotide with 8-oxoguanine at the 10th position
(Trevigen) was end-labeled.  The labeling reaction contained 5 pmol of single-strand 8-oxoguanine
oligonucleotide, 5 pmol of γ-32 P, T4 polynucleotide kinase, and appropriate kinase buffer in a total
volume of 20 µl (incubation for 30 min at 37o C followed by 2 min at 90o C). Complementary
oligonucleotide (5 pmol) was then added at room temperature to form duplex DNA.  Equal amounts of
protein from mitochondrial fractions isolated from transfected cells grown in media with or without Dox
were used in assays with the labeled duplex oligonucleotide.  Activity assays contained 0.2 pmol of labeled
duplex oligonucleotide , 3 µl of 10XREC buffer (100 mM HEPES, pH 7.4, 1M KCl,  100 mM EDTA, and
1  mg/ml BSA) and organelle extract or 5 U of control formamidopyrimidine DNA glycosylase enzyme
(Trevigen) in a total volume of 20 µl.  Reaction mix was incubated for 3 and 6 h at 37o C. Formamide/
bromphenol (80%/0.2%) dye was added to the mix and reaction products were resolved in 20% acrylamide,
8 M urea gels.
Drug Preparation and Exposure - For oxidative damage and repair experiments, cells were grown
in 100 mm dishes for four days in media with or without Dox until 70-80% confluence. Menadione sodium
bisulfite (2-methyl-1, 4-naphthoquinone sodium bisulfite, Sigma, St.Louis, MO) was dissolved in Hanks’ 
balanced salt solution (HBSS) at a concentration of 800 µM for DNA repair experiments.  Cells were
rinsed with HBSS and then exposed to the appropriate amount of menadione for 20 min in a 37oC, 5%
CO2 incubator.  Control cultures were exposed to HBSS under the same conditions.  After a 20 min exposure,
cells were rinsed and lysed immediately (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 0.5% SDS, and 0.3
mg/ml proteinase K), or were allowed to repair for 2 or 6 h in regular growth media with or without Dox.
Quantitative and Neutral Southern Blots - MTS-OGG transfected and vector-only transfected
cells were exposed to menadione as described above and cell lysates were incubated overnight at 37oC.
After addition of NaCl to a final concentration of 1 M, high molecular weight DNA was extracted with an
equal volume of chloroform:isoamyl alcohol (24:1), precipitated with ammonium acetate and 2 volumes of
cold ethanol and resuspended in water.  DNA samples were digested with restriction endonuclease XhoI 
(10 units/µg of DNA) and, at the same time, treated with DNAse-free- RNase (~1.0 µg/ml) for 12-16 h at
37oC.  After digestion, samples were precipitated as before, resuspended in TE buffer (10 mM Tris, 1 mM
EDTA, pH 7.4)  and precisely quantified using a Hoefer TKO 100 Mini-Fluorometer and TKO standards
kit (Hoefer Scientific Instruments, San Francisco, CA).  Samples containing 5 µg DNA were heated at
6
65oC for 20 min and then cooled at room temperature for an additional 20 min.  A sodium hydroxide solution
then was added to a final concentration of 0.1 N and samples were incubated for 15 min at 37oC.  This
produced single strand breaks at any abasic or sugar-modified site in the DNA. Next, samples were
combined with 5 µl of loading dye, loaded onto a 0.6% alkaline agarose gel and electrophoresed at 30 Volts
(1.5 Volts/ cm gel length) for approximately 16 h in an alkaline buffer consisting of 23 mM NaOH, 1 mM
EDTA.  The gels were stained with ethidium bromide to confirm equal loading.  After standard gel
washing, the DNA was transferred to a Zeta-Probe GT nylon membrane (BioRad, Hercules, CA). The
membranes were cross-linked and hybridized with a 32P-labeled human mtDNA-specific PCR-generated
probe.  Hybridization and subsequent washes were performed according to the manufacturer’s 
recommendations.  DNA damage and repair were determined as described previously (30).  Neutral
Southern blots were performed the same way, except that there was no alkaline pretreatment of samples
and NaOH was not included in the loading dye, the 0.6% agarose gel, or the electrophoresis buffer.  To
confirm integration into the genome of the pTRE2hyg/MTS-OGG1 plasmid, DNA samples were digested
with BamHI and HindIII, and hybridization was performed with a 32P-labeled MTS-OGG1 fragment
generated using the RadPrime Labelling System (Life Technologies, Inc.).
Clonogenic Assays - Cells were counted with a hemocytometer and 250 cells were plated in each
60 mm dish to achieve sparse distribution.  These cells were incubated for 24 h in normal culture medium
to allow them to adhere to the culture vessel. Next, they were exposed to menadione exactly as described
above, with the exception that lower concentrations of the drug were used due to the higher sensitivity of
cells to oxidative stress when plated at the low density required for the clonogenic assay.  For each cell
type, controls (no menadione) and cultures receiving various concentrations of menadione were studied in
triplicate.  After 20 min of treatment, the menadione solution was replaced with normal culture medium
(with or without Dox) and cells were grown for 10 days. Then colonies formed were stained with
hematoxylin and counted.
Statistical Analysis – The data are presented as the means + standard errors of three independent
experiments.  Data were compared with the use of two-way ANOVA followed by Bonferroni analysis.
Statistical significance was determined at the 0.001 level.
RESULTS
Generation of Double Transfected Cell Lines – To fully evaluate the potential of using
recombinant hOGG1 to alter mtDNA repair, we used HeLa cells transfected with MTS-OGG1 under the
control of a Tet-mediated promoter.  Initially, HeLa cells were stably transfected with the pTet-Off
regulator plasmid.  Following two weeks of selection, individual clones were isolated and the integration of
the tTa activator was confirmed by PCR amplification.  Expression of tTa was checked by Luc-assay after
transient transfection of Tet-Off clones with a reporter plasmid pTRE2hyg/Luc.  Selected clones were
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grown in the absence and presence of Dox.  Clones that expressed the lowest basal level of luciferase and
showed the highest induced level (> 50 fold induction) of Luc-activity after Dox removal were chosen for
the second transfection with the pTRE2hyg/MTS-OGG1 construct or control vector (pTRE2hyg).
Double transfected clones were selected in hygromycin and grown in the presence of Dox.  DNA
was isolated from cells transfected with MTS-OGG1 or vector only, and the presence of the insert was
confirmed in the MTS-OGG1 transfected clones by hybridization with a 1.1 kb fragment containing a
partial MTS-OGG1 sequence (Fig. 1).  A clone of HeLa Tet-Off/MTS-OGG1-1 was chosen for
subsequent study because it exhibited the highest level of MTS-OGG1 incorporation into its genome and
produced the greatest amount of OGG1 protein in mitochondria after induction (Fig. 2).
Dox-Dependant Overexpression of OGG1 in Mitochondria - In order to show that the
recombinant OGG1 enzyme was targeted directly to mitochondria and its expression was regulated by Dox,
mitochondrial extracts were isolated from MTS-OGG1 and vector only transfected clones which were
grown in media with or without Dox.  Mitochondria were isolated by differential centrifugation and
western blots were performed utilizing a polyclonal antibody to human OGG1.  Even loading was
confirmed by Coomassie Blue staining.  The Tet-Off/MTS-OGG1-1 Dox- clone showed an increase in
OGG1 protein (39 kDA) when compared to Dox+ Tet-Off/MTS-OGG1 repressed cells or vector-
transfected cells (Fig. 2).  This data confirmed that the recombinant OGG1 enzyme was targeted to
mitochondria, and that OGG1 gene expression was regulated by Dox.
Dox-Dependant OGG1 Activity in Mitochondria - To determine whether the recombinant OGG1
was functional in mitochondria, OGG1-activity assays were performed.  A labeled 24 - base pair duplex
oligonucleotide with 8-oxoguanine placed at the 10th position on one strand was incubated with
mitochondrial extracts isolated from MTS-OGG1 and vector-transfected cells.  As a positive control, the
bacterial glycosylase/AP-lyase FPG (Trevigen) was used.  As shown in Fig. 3, the mitochondrial extracts
isolated from MTS-OGG1 (Dox-) clones were better able to cleave the DNA substrate than were the same
cells grown in the presence of Dox and vector only transfected cells.  Thus, this data reveals that the
conditionally expressed recombinant OGG1 protein, which is targeted to mitochondria, is indeed
functional.
Dox-Mediated Overexpression of OGG1 in Mitochondria and mtDNA Repair - To test whether
the conditional overexpression of recombinant hOGG1 in the mitochondria has an effect on mtDNA repair
capacity, an analysis of DNA repair was performed.  To detect mtDNA damage and repair a quantitative
Southern blot technique was used as described in the “Experimental Procedures”.  First, dose response
experiments were performed using different concentrations of menadione, which redox cycles with
complex I of the electron transport chains in mitochondria and forms superoxide radical (31).  A
concentration of 800 µM menadione was chosen for the repair experiments because it produced an
appropriate amount of lesions (~1 lesion per 104 normal nucleotides).  There was no significant difference
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in the initial break frequencies between clones which were grown in the absence or presence of Dox.
Repair experiments were performed in which the MTS-OGG1 and vector transfectants were exposed to
800 µM menadione for 20 min and either lysed immediately or allowed to repair for 2 or 6 h in normal
culture media with or without Dox.  Control cells were incubated in drug diluent only. Total DNA was
isolated from the lysed cells and quantitative Southern blot hybridizations were performed. As shown in
Fig. 4A, the MTS-OGG1 (Dox-) clones repaired most of the damage within the initial 6 h following drug
removal, whereas the vector transfectants and MTS-OGG1 (Dox+) clones did not repair an appreciable
amount of the damage to their mtDNA.  The average amount of repair from three separate experiments for
each cell type is shown in Fig. 4B.  These results document that recombinant hOGG1, when conditionally
overexpressed and targeted to mitochondria, significantly enhances mtDNA repair of oxidative damage.
The Effect of Conditional Overexpression of OGG1 in Mitochondria on Cellular Viability - To
determine whether the increase in mtDNA repair enhanced cellular survival following oxidative stress, a
clonogenic assay was performed.  Because sparsely growing cells are more sensitive to menadione than
confluent monolayers, for these clonogenic studies we used lower doses of menadione than were required
for the DNA repair experiments.  Drug exposure and cellular growth in the presence or absence of Dox was
performed using techniques described in the “Experimental Procedures” section.  The colonies formed
from cells that survived and proliferated following oxidative stress were counted after 10 days of culture.
Fig. 5 shows that there is a significant enhancement in survival in the MTS-OGG1 (Dox-) transfectants.
These viability data establish that conditional transduction of OGG1 in mitochondria leads to increased
cellular survival after an oxidative challenge.
DISCUSSION
To our knowledge, this is the first report to show conditional expression of a recombinant DNA
repair enzyme which is targeted to mitochondria. Previous studies by our laboratory showed that when a
vector containing the gene for hOGG1 fused to the localization sequence from MnSOD was stably
transfected into HeLa cells, repair of oxidative damage in mtDNA was increased and cellular survival
enhanced (27).  Although this work provided some important new information concerning repair of
oxidative damage in mtDNA, the results had to be interpreted with caution because permanent transfection
could have altered the genome of the cell in a manner that influenced the findings.  To overcome this
problem, the present experiments were initiated to find a “genetic switch” that would allow the control of
individual gene products quantitatively and reversibly in a temporal manner.  Among the several regulatory
systems currently available, the tetracycline (Tet)-controlled system for the activation of transcription
seemed best suited to fulfill the requirements of our study.  Previously, this system has been used for
conditional gene expression in mammalian cell culture (38), in transgenic plants (39), and in transgenic
mice and other transgenic mammalian species  (40, 41).  HeLa cells were selected for this study because we
previously discovered that these cells do not proficiently repair oxidative damage to their mtDNA (27), and
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it has been reported that in these cells the Tet-systems exhibit no measurable “intrinsic leakiness”  (28,
32). Repair of oxidative damage in the nucleus of these cells appears to be normal. This makes these cells
preferable to cells in which OGG1 has been knocked out because those cells would be defective in both
nuclear and mitochondrial repair. Although the reason that HeLa cells are defective in the repair of
oxidative damage in mtDNA has yet to be fully elucidated, we believe a likely explanation is that there is a
defect in the formation of the alternatively spliced transcript for mitochondrial localization. In support of
this notion is our finding that HeLa cells have low levels of OGG1 protein in their mitochondria. 
For targeting OGG1 to mitochondria we used the MTS from MnSOD,  because previous work
from our laboratory and the studies of others have found this to be a particularly strong MTS that
effectively directs other proteins, including repair enzymes, to mitochondria  (27, 33-35).  We used the
Tet-Off system, where the presence of Dox prevents transcriptional activation, for conditional expression
of hOGG1 in mitochondria.  This system was used because in the clones we isolated the amount of hOGG1
that could be produced was greater than with the Tet-On system.  In the presence of Dox the exogenous
recombinant MTS-OGG1 expression in mitochondria was low, and the cells behaved similarly in culture to
the HeLa Tet-Off cell line, transfected with vector only.
Both the results from enzyme activity assays and DNA repair studies reveal that the Dox-
dependent, expressed MTS-OGG1 is functional.  The mitochondrial extracts isolated from MTS-OGG1
(Dox-) cells were markedly better able to cleave substrate than the same cells grown with Dox and vector
only transfected cells.  Mitochondrial DNA repair studies show that MTS-OGG1 (Dox-) cells were
significantly more proficient at repairing oxidative damage in the mitochondrial genome.  Combined with
the viability studies, it can be concluded that recombinant OGG1 was conditionally expressed under the
Dox-inducible promoter, and targeted to mitochondria in an active form. Furthermore, it enhanced the
repair of oxidative damage to the sugar-phosphate backbone in mtDNA, and this augmented repair
rendered the cells more resistant to oxidative stress.  Thus, these findings support previous work from our
laboratory using cells which constitutively overexpress OGG1 and provide a new opportunity for dissecting
the various components of BER in mitochondria.  Recently, much attention has been directed toward the
identification and characterization of enzymes involved in BER of mtDNA.  Initial evidence for a BER
mechanism in mitochondria was provided by the isolation of a mammalian mitochondrial endonuclease that
specifically recognizes AP sites and cleaves the DNA strand (36).  Later, activities of an AP endonuclease,
a DNA ligase III, and a DNA polymerase   were identified in mitochondrial fractions from Xenopus
oocytes (17).  Additionally, a mitochondrial Oxidative Damage Endonuclease (mtODE) has been isolated
from rat liver mitochondria (37).  Recently, it was demonstrated that mtODE is a mitochondrial isoform of
OGG1 (26).  Although several of the enzymes involved in mtDNA BER have been identified, a thorough
understanding of the exact roles these enzymes play is still incomplete.  The results from the present study
emphasize the crucial role that hOGG1 plays in the efficient repair of oxidative damage in mtDNA.  Future
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studies will be directed toward the conditional expression of other repair enzymes with glycosylase activity
to other oxidative base lesions and lyase activity to better understand the importance of these activities in
BER. Of particular interest is a second OGG activity, originally termed OGG2, which has been identified
and partially characterized in HeLa cells (42). Also of immediate interest are two orthologs of MutM/Nei
which have been identified in the human genome database and were originally named NEH1 and NEH2
(42).  Both enzymes have since been renamed to NEIL1 and NEIL2. NEIL1 functions as a DNA
glycosylase/AP lyase with broad substrate specificity (42), whereas NEIL2 has DNA glycosylase/AP lyase
activity, which primarily recognizes oxidized cytosine derivatives (43).  
The importance of mtDNA integrity for normal cellular homeostasis is only beginning to be
appreciated.  Because increased oxidative lesions are found in mtDNA in individuals with a variety of
chronic diseases (1-9), regulated expression of mitochondrial repair enzymes may provide a beneficial
gene therapeutic strategy for preventing or delaying the symptoms of these diseases.  Additionally,
conditional expression of repair enzymes may be a viable approach for protecting normal cells during
cancer therapy, or sensitizing cancer cells to this treatment.  This work represents some of the initial steps
down this path.
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FIGURE LEGENDS
Fig. 1.  The MTS-OGG1 Insert is Incorporated into HeLa Tet-Off Cells.
A Southern blot was performed on total DNA isolated from seven HeLa Tet-Off clones transfected with
the MTS-OGG1 construct, or a clone transfected with vector alone using the MTS-OGG1 sequence as a
probe.
Fig. 2.  Dox-Regulated and Targeted Expression of OGG1 in Mitochondria. 
HeLa Tet-Off/ MTS-OGG1 transfected clones were cultured with or without 1 µg/ml Dox for four days to
regulate OGG1 protein expression.  Mitochondrial fractions were isolated and analyzed by Western blot
analysis using anti OGG1 antiserum.  Twenty µg of mitochondrial extracts isolated from vector and MTS-
OGG1 transfected clones were loaded in each lane.  Immunodetection of cytochrome C was performed to
assure that the recombinant protein is in mitochondria.  
Fig. 3.  Dox-Regulated OGG1 Activity in Mitochondria. 
Enzyme activity was measured using a labeled 24 -mer containing 8-OxoG.  Mitochondrial fractions were
isolated from vector and MTS-OGG1 transfected clones that had been maintained with and without Dox
and the extracts incubated with labeled substrate.  A significant increase of 9- mer cleavage product was
observed in lanes containing extracts from MTC-OGG1 (Dox-) clones, indicating that OGG1 activity was
significantly higher in those clones.  The data represent three independent experiments.
Fig. 4.  Effect of Conditional Expression of OGG1 in Mitochondria on the Repair of Oxidative Damage to
the Sugar-Phosphate Backbone in mtDNA. 
MTS-OGG1 and vector transfectants were treated with 800 µM menadione for 20 min and lysed
immediately or allowed to repair for 2 or 6 h in normal culture media with or without Dox. Control cells
were exposed to the drug diluent only.  Total DNA was isolated from the lysed cells and quantitative
alkaline Southern blot hybridizations with mtDNA specific probe were performed.  4A is a representative
autoradiograph.  4B is a summation of the results of three independent experiments (values are the means + 
SE of three separate experiments).  An asterisk (*) indicates a significant difference (p<0.001).
Fig. 5.  OGG1 Dox-Regulated Expression and Cell Survival and Proliferation.
Cells were maintained in the Dox + media for four days and than were plated at low density into 60-mm
dishes and allowed to adhere to the culture vessel for 24 h.  They next were drugged with 25, 50, 75, or 100 
 µM menadione for 20 min and replenished with their normal media with or without Dox.  Cells in cultures
were allowed grow for ten days, at which time the cultures were fixed, stained with hematoxylin, and
colonies counted.  An average of the results + SE from three separate clonogenic assays is shown.  An
12
asterisk (*) indicates a significant difference (p<0.001).
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